400-0755-639
联系微信客服
首页 搜索结果
搜索关键词为“”,共搜索43312条结果
Sibrafiban
目录号:SY-109794
Sibrafiban (RO 48-3657) 是一种 Ro 44-3888 的口服非肽双前药,是一种选择性的糖蛋白 IIb/IIIa 受体 (glycoprotein IIb/IIIa receptor) 拮抗剂。Sibrafiban 能够抑制血小板聚集。
¥737.00
查看详情
Fibronectin Active Fragment Control
目录号:SY-109796
Fibronectin is a high-molecular weight (~440kDa) extracellular matrix glycoprotein that binds to membrane-spanning receptor proteins called integrins.In addition to integrins, fibronectin also binds extracellular matrix components such as collagen, fibrin
询价
查看详情
Fradafiban
目录号:SY-109797
Fradafiban binds to the human platelet GP IIb/IIIa complex with a Kd value of 148 nM. Fradafiban is a non-polypeptide platelet glycoprotein IIb/IIIa antagonist.
¥19205.00
查看详情
α2β1 Integrin Ligand Peptide
目录号:SY-109798
The Asp-Gly-Glu-Ala (DGEA) amino acid domain of type I collagen interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells. It is a potential antagonist of collagen receptors.
¥418.00
查看详情
Solitomab
目录号:SY-109799
Solitomab(AMG 110)是一种靶向CD3与EpCAM/CD326(上皮细胞粘附分子)的双特异性单链抗体,对原发性子宫癌和卵巢癌肉瘤细胞系具有体外活性。
¥6160.00
查看详情
Caplacizumab
目录号:SY-109800
Caplacizumab (ALX-0681)为人源化抗血管性血友病因子(vWF)纳米抗体,具有抑制vWF介导的血小板粘附作用,可阻止微血栓进一步形成。该化合物在血栓性血小板减少性紫癜(TTP)研究中应用。
¥3420.00
查看详情